Clinical trial
Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related…
NCT00412100 · Mundipharma Research GmbH & Co KG, Industry · Completed
Key facts
| NCT number | NCT00412100 |
|---|---|
| Title | Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation |
| Official title | A Randomsied, Double-blind, Double-dummy, Parallel-group Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-malignant Pain Taking Oxycodone Equivalent of 60-80 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged… |
| Lead sponsor | Mundipharma Research GmbH & Co KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Oxycodone naloxone prolonged release tablets (OXN) |
| Start date | Apr 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Dec 15, 2006 |
| Last update posted | Oct 23, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: